TY - JOUR
T1 - Ductal lavage and ductoscopy
T2 - The opportunities and the limitations
AU - Khan, Seema A.
AU - Baird, Carol
AU - Staradub, Valerie L.
AU - Morrow, Monica
PY - 2002/8
Y1 - 2002/8
N2 - Two related techniques of breast epithelial sampling have emerged in the past several years: ductal lavage, in which fluid-yielding nipple ducts are cannulated at their orifices and lavaged with saline while the breast is intermittently massaged; and ductoscopy, in which discharging or fluid-yielding duct orifices are dilated, intubated with a microendoscope, and the lumen directly visualized. Both of these techniques have significant potential in terms of allowing the repeated sampling of ductal epithelium over time and, as such, have generated considerable enthusiasm. However, data regarding the impact of these techniques on the detection of significant breast disease is very scant. It is important at the outset of the assessment of this new technology that breast cancer clinicians and clinical researchers think carefully about the standards of evidence that need to be met regarding the benefits of these procedures before they are widely adopted. In this review of the rationale and early results of these procedures, we attempt to define some of these evidentiary requirements.
AB - Two related techniques of breast epithelial sampling have emerged in the past several years: ductal lavage, in which fluid-yielding nipple ducts are cannulated at their orifices and lavaged with saline while the breast is intermittently massaged; and ductoscopy, in which discharging or fluid-yielding duct orifices are dilated, intubated with a microendoscope, and the lumen directly visualized. Both of these techniques have significant potential in terms of allowing the repeated sampling of ductal epithelium over time and, as such, have generated considerable enthusiasm. However, data regarding the impact of these techniques on the detection of significant breast disease is very scant. It is important at the outset of the assessment of this new technology that breast cancer clinicians and clinical researchers think carefully about the standards of evidence that need to be met regarding the benefits of these procedures before they are widely adopted. In this review of the rationale and early results of these procedures, we attempt to define some of these evidentiary requirements.
KW - Breast cancer
KW - Cellular atypia
KW - Ductal carcinoma in situ
KW - Nipple fluid aspiration
KW - Risk assessment
UR - http://www.scopus.com/inward/record.url?scp=0036695681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036695681&partnerID=8YFLogxK
U2 - 10.3816/CBC.2002.n.022
DO - 10.3816/CBC.2002.n.022
M3 - Review article
C2 - 12196274
AN - SCOPUS:0036695681
SN - 1526-8209
VL - 3
SP - 185
EP - 191
JO - Clinical breast cancer
JF - Clinical breast cancer
IS - 3
ER -